Israeli medtech firm raised $15M to treat heart-failure patients with catheter-based therapy

Acute heart failure affects about 6.5 million people in the United States, with 960,000 new cases diagnosed annually, based on data from the American Heart Association.

Executives at Israel-based Magenta Medical believe that the company’s catheter-based therapy can prevent scores of heart failure-related hospital admissions that result from fluid build-up that burdens the heart and kidneys.

Read more..